Literature DB >> 1829286

Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process.

S Aihara1, C M Rao, Y X Yu, T Lee, K Watanabe, T Komiya, H Sumiyoshi, H Hashimoto, A Nomoto.   

Abstract

The total nucleotide sequences of the genomes of two Japanese encephalitis virus (JEV) strains, the attenuated vaccine strain SA14-14-2 and its parental virulent strain SA14, were determined by using the molecular cloning technique. The sequence analysis revealed that both virion RNA molecules were 10,976 nucleotides long with 95 and 585 flanking bases at the 5' and 3' untranslated sequences, respectively. A single, long open reading frame spanning 10,296 nucleotides was observed to encode a polyprotein of 3432 amino acid residues. When these sequences were compared with each other, 57 nucleotide substitutions were found to be scattered all over the genome. Of these, 24 resulted in amino acid changes within viral proteins. Structural proteins C and E contain one and eight amino acid changes, respectively. Of the nonstructural proteins, NS1 contains three, NS2a two, NS2b two, NS3 four, NS4a one, NS4b one, and NS5 two amino acid substitutions. The 5'- and 3'-terminal untranslated regions contain one- and two- point mutations, respectively. These data and comparative studies with other JEV strain genomes provide a molecular basis for investigating attenuation mechanisms of JEV.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829286     DOI: 10.1007/bf00571925

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  21 in total

1.  Gene mapping and positive identification of the non-structural proteins NS2A, NS2B, NS3, NS4B and NS5 of the flavivirus Kunjin and their cleavage sites.

Authors:  G Speight; G Coia; M D Parker; E G Westaway
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

2.  Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication.

Authors:  S Kuge; A Nomoto
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses.

Authors:  Y S Hahn; R Galler; T Hunkapiller; J M Dalrymple; J H Strauss; E G Strauss
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

4.  Molecular basis of Sindbis virus neurovirulence in mice.

Authors:  S Lustig; A C Jackson; C S Hahn; D E Griffin; E G Strauss; J H Strauss
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

Review 5.  Strategy for construction of live picornavirus vaccines.

Authors:  A Nomoto; N Iizuka; M Kohara; M Arita
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

6.  A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.

Authors:  M Kohara; S Abe; T Komatsu; K Tago; M Arita; A Nomoto
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

8.  Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses.

Authors:  A Igarashi
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

9.  Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis.

Authors:  T J Chambers; D W McCourt; C M Rice
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

10.  Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

Authors:  K H Eckels; Y X Yu; D R Dubois; N J Marchette; D W Trent; A J Johnson
Journal:  Vaccine       Date:  1988-12       Impact factor: 3.641

View more
  17 in total

1.  Mutagenesis of the NS3 protease of dengue virus type 2.

Authors:  R P Valle; B Falgout
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

2.  A second group of hepatitis C viruses.

Authors:  K Tsukiyama-Kohara; M Kohara; K Yamaguchi; N Maki; A Toyoshima; K Miki; S Tanaka; N Hattori; A Nomoto
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

3.  Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.

Authors:  T P Monath; I Levenbook; K Soike; Z X Zhang; M Ratterree; K Draper; A D Barrett; R Nichols; R Weltzin; J Arroyo; F Guirakhoo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.

Authors:  Gregory D Gromowski; Cai-Yen Firestone; José Bustos-Arriaga; Stephen S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

5.  Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.

Authors:  Gregory D Gromowski; Cai-Yen Firestone; Stephen S Whitehead
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

6.  Use of NS3 consensus primers for the polymerase chain reaction amplification and sequencing of dengue viruses and other flaviviruses.

Authors:  V T Chow; C L Seah; Y C Chan
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.

Authors:  Thomas P Monath; Juan Arroyo; Inessa Levenbook; Zhen-Xi Zhang; John Catalan; Ken Draper; Farshad Guirakhoo
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

Authors:  J Arroyo; F Guirakhoo; S Fenner; Z X Zhang; T P Monath; T J Chambers
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

9.  Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice.

Authors:  A G Pletnev; M Bray; C J Lai
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.

Authors:  Byung-Hak Song; Gil-Nam Yun; Jin-Kyoung Kim; Sang-Im Yun; Young-Min Lee
Journal:  J Microbiol       Date:  2012-08-25       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.